Literature DB >> 19556894

The cellular prion protein and its role in Alzheimer disease.

J L Velayos1, A Irujo, M Cuadrado-Tejedor, B Paternain, F J Moleres, V Ferrer.   

Abstract

The cellular prion protein (PrP(C)) is a membrane-bound glycoprotein especially abundant in the central nervous system (CNS). The scrapie prion protein (PrP(Sc,) also termed prions) is responsible of transmissible spongiform encephalopathies (TSE), a group of neurodegenerative diseases which affect humans and other mammal species, although the presence of PrP(C) is needed for the establishment and further evolution of prions. The present work compares the expression and localization of PrP(C) between healthy human brains and those suffering from Alzheimer disease (AD). In both situations we have observed a rostrocaudal decrease in the amount of PrP(C) within the CNS, both by immunoblotting and immunohistochemistry techniques. PrP(C) is higher expressed in our control brains than in AD cases. There was a neuronal loss and astogliosis in our AD cases. There was a tendency of a lesser expression of PrP(C) in AD cases than in healthy ones. And in AD cases, the intensity of the expression of the unglycosylated band is higher than the di- and monoglycosylated bands. With regards to amyloid plaques, those present in AD cases were positively labeled for PrP(C), a result which is further supported by the presence of PrP(C) in the amyloid plaques of a transgenic line of mice mimicking AD. The work was done according to Helsinki Declaration of 1975, and approved by the Ethics Committee of the Faculty of Medicine of the University of Navarre.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556894      PMCID: PMC2712608          DOI: 10.4161/pri.3.2.9135

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  27 in total

1.  Prion protein expression in senile plaques in Alzheimer's disease.

Authors:  I Ferrer; R Blanco; M Carmona; B Puig; R Ribera; M J Rey; T Ribalta
Journal:  Acta Neuropathol       Date:  2001-01       Impact factor: 17.088

2.  Developmental changes in cellular prion protein in primate visual cortex.

Authors:  Isabelle Laffont-Proust; Caroline Fonta; Luc Renaud; Raymonde Hässig; Kenneth L Moya
Journal:  J Comp Neurol       Date:  2007-10-20       Impact factor: 3.215

3.  Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke.

Authors:  Nicholas Mitsios; Mohamad Saka; Jerzy Krupinski; Roberta Pennucci; Coral Sanfeliu; Marta Miguel Turu; John Gaffney; Pat Kumar; Shant Kumar; Matthew Sullivan; Mark Slevin
Journal:  J Neurosci Res       Date:  2007-02-15       Impact factor: 4.164

4.  Retrograde transport of transmissible mink encephalopathy within descending motor tracts.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases.

Authors:  M M Esiri; J Carter; J W Ironside
Journal:  Neuropathol Appl Neurobiol       Date:  2000-06       Impact factor: 8.090

6.  Oxidative damage to nucleic acids in human prion disease.

Authors:  Marin Guentchev; Sandra L Siedlak; Christa Jarius; Fabrizio Tagliavini; Rudy J Castellani; George Perry; Mark A Smith; Herbert Budka
Journal:  Neurobiol Dis       Date:  2002-04       Impact factor: 5.996

7.  Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF).

Authors:  John A Hamilton; Genevieve Whitty; Anthony R White; Michael F Jobling; Andrew Thompson; Colin J Barrow; Roberto Cappai; Konrad Beyreuther; Colin L Masters
Journal:  Brain Res       Date:  2002-06-14       Impact factor: 3.252

8.  Aging, the brain and human prion disease.

Authors:  Gábor G Kovács; Herbert Budka
Journal:  Exp Gerontol       Date:  2002-04       Impact factor: 4.032

9.  An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.

Authors:  Elisabete Ferreiro; Rosa Resende; Rui Costa; Catarina R Oliveira; Cláudia M F Pereira
Journal:  Neurobiol Dis       Date:  2006-07-17       Impact factor: 5.996

10.  Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Authors:  Juha Laurén; David A Gimbel; Haakon B Nygaard; John W Gilbert; Stephen M Strittmatter
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

View more
  10 in total

1.  Regulation of amyloid-β production by the prion protein.

Authors:  Heledd H Griffiths; Isobel J Whitehouse; Nigel M Hooper
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

2.  Unaltered prion protein expression in Alzheimer disease patients.

Authors:  Eri Saijo; Stephen W Scheff; Glenn C Telling
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

Review 3.  Prion protein and Alzheimer disease.

Authors:  Katherine A B Kellett; Nigel M Hooper
Journal:  Prion       Date:  2009-10-02       Impact factor: 3.931

4.  Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.

Authors:  C Vergara; L Ordóñez-Gutiérrez; F Wandosell; I Ferrer; J A del Río; R Gavín
Journal:  Mol Neurobiol       Date:  2014-06-26       Impact factor: 5.590

5.  Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes.

Authors:  Jo V Rushworth; Nigel M Hooper
Journal:  Int J Alzheimers Dis       Date:  2010-12-27

Review 6.  Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer's Disease.

Authors:  Yuan Zhang; Yanfang Zhao; Lei Zhang; Wanpeng Yu; Yu Wang; Wenguang Chang
Journal:  Front Cell Neurosci       Date:  2019-07-30       Impact factor: 5.505

7.  Brain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrP(C)), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum differentiate urban children exposed to severe vs. low air pollution.

Authors:  Lilian Calderón-Garcidueñas; Janet V Cross; Maricela Franco-Lira; Mariana Aragón-Flores; Michael Kavanaugh; Ricardo Torres-Jardón; Chih-Kai Chao; Charles Thompson; Jing Chang; Hongtu Zhu; Amedeo D'Angiulli
Journal:  Front Neurosci       Date:  2013-10-10       Impact factor: 4.677

8.  Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo.

Authors:  Kyongman An; Igor Klyubin; Youngkyu Kim; Jung Hoon Jung; Alexandra J Mably; Sean T O'Dowd; Timothy Lynch; Daniel Kanmert; Cynthia A Lemere; Gina M Finan; Joon Won Park; Tae-Wan Kim; Dominic M Walsh; Michael J Rowan; Joung-Hun Kim
Journal:  Mol Brain       Date:  2013-11-13       Impact factor: 4.041

9.  Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.

Authors:  Reisuke H Takahashi; Mayumi Yokotsuka; Minoru Tobiume; Yuko Sato; Hideki Hasegawa; Toshitaka Nagao; Gunnar K Gouras
Journal:  Brain Pathol       Date:  2021-02-23       Impact factor: 6.508

Review 10.  Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.

Authors:  Huiqin Zhang; Wei Wei; Ming Zhao; Lina Ma; Xuefan Jiang; Hui Pei; Yu Cao; Hao Li
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.